An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients. (RUBATO OL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03775421 |
|
Recruitment Status :
Recruiting
First Posted : December 14, 2018
Last Update Posted : October 28, 2020
|
Sponsor:
Actelion
Collaborators:
Covance
Henry Ford Health System
Almac Clinical Technologies
ActiGraph LLC
Medidata Solutions
Information provided by (Responsible Party):
Actelion
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | November 7, 2022 |
| Estimated Study Completion Date : | March 31, 2024 |